ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $264,663 | -51.9% | 8,394 | -61.0% | 0.19% | -54.8% |
| Q3 2023 | $550,296 | -19.4% | 21,538 | -9.6% | 0.42% | -5.6% |
| Q2 2023 | $683,158 | +16.6% | 23,820 | -2.5% | 0.45% | +9.0% |
| Q1 2023 | $585,707 | +47.2% | 24,435 | +4.2% | 0.41% | +24.2% |
| Q4 2022 | $398,000 | +15.0% | 23,441 | +0.3% | 0.33% | +13.0% |
| Q3 2022 | $346,000 | -71.2% | 23,362 | -69.4% | 0.29% | +6.2% |
| Q2 2022 | $1,200,000 | +93.5% | 76,250 | +231.3% | 0.28% | -34.0% |
| Q1 2022 | $620,000 | -20.0% | 23,013 | +9.9% | 0.42% | -20.1% |
| Q4 2021 | $775,000 | -19.8% | 20,949 | +3.6% | 0.52% | -21.6% |
| Q3 2021 | $966,000 | +57.6% | 20,223 | +11.6% | 0.67% | +60.0% |
| Q2 2021 | $613,000 | – | 18,122 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |